A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

Bayer80 enrolled

Overview

To show therapeutic efficacy of Zarzenda cream compared to Elidel cream in children and adolescents with mild to moderate atopic dermatitis

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Mild to Moderate Atopic Dermatitis

Interventions

ZarzendaDEVICE

Topical cream, applied twice daily for three weeks

ElidelDRUG

1% cream, applied topically twice daily for three weeks

Eligibility

Sex: ALLMin age: 2 YearsMax age: 17 Years

Medical Language ↔ Plain English

Inclusion Criteria: * male and female children and adolescents (aged 2 - 17) * mild to moderate atopic dermatitis * patients in whom a treatment with topical corticosteroids in not recommended or possible * wash out periods to be observed Exclusion Criteria: * known allergy to one of the two treatments * known immunodeficiency * known hepatic or renal insufficiency * acute skin infections

Locations (1)

Klinik und Poliklinik fuer Dermatologie, Universtitaetsklinikum

Bonn, Germany